TuHURA BIOSCIENCES, INC./NV Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
TuHURA BIOSCIENCES, INC./NV (HURA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 51.09 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-14
- TuHURA BIOSCIENCES, INC./NV antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 52.05M shares, a 250.57% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 14.85M shares, a 51.40% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 30.55M shares.
- TuHURA BIOSCIENCES, INC./NV antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 41.68M shares, a 144.95% increase from fiscal 2024.
- TuHURA BIOSCIENCES, INC./NV antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 17.01M shares, a 40.56% decline from fiscal 2023.
- TuHURA BIOSCIENCES, INC./NV antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 28.63M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 51.09M shares 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | 52.05M shares 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | 41.68M shares 10-K · filed 2026-03-31 | |||
| 2025-09-30 | 19.58M shares 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | 18.64M shares 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | 14.85M shares 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | 17.01M shares 10-K · filed 2026-03-31 | |||
| 2024-09-30 | 39.11M shares 10-Q · filed 2025-11-14 | |||
| 2024-06-30 | 36.23M shares 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | 30.55M shares 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | 28.63M shares 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |